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Conclusion: In STEMI patients treated with primary PCI, increased admission serum
creatinine was strongly associated with 12-month mortality and CIN.
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Background: The aim of study is to compare the 4 years clinical outcome of stent
implantation with bare metal stent (BMS), first generation (sirolimus-eluting and
paclitaxel eluting stent: 1st DES) and second generation (Xience V and Nobori: 2nd
DES) drug-eluting stent implantation in chronic renal failure with dialysis (CRF-HD).
Methods: A prospective analysis of 898 CRF-HD patients with CAD (288 BMS, 311
1st DES and 299 2nd DES) in five high volume Asian centers after successful stenting
was performed. The study endpoints were all cause of death and major adverse cardiac
events (MACE: death, MI, CABG, CV event and re-PCI) at 4 years.
Results: The baseline clinical characteristics between 3 groups were similar. See
figures for clinical results.
Conclusion: The use of 2nd generation drug-eluting stents in patient with CRF-HD
was significantly lesser incidence of MACE than that of BMS at 4 years.
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Background: Contrast-induced nephropathy (CIN) is the third most common cause
of hospital acquired acute renal failure and is associated with increased morbidity and
mortality. Among risky patients, only intravenous (IV) hydration has proved effective
for prevention. The use of theophylline, a selective renal adenosine antagonist has
yielded conflicting results. The aim of this study was to examine the effectiveness of
theophylline in prevention of CIN when added to IV hydration and N-acetylcysteine
(NAC) in moderate and higher risk patients.
Methods: Sixty patients with stable serum creatinine and at least moderate risk for
CIN according to Mehran’s risk score were included in this parallel-group, 1:1, single-
blind, randomized controlled trial. Patients were randomized to IV hydration (1ml/kg/h
for 24 h), NAC (600 mg bid for 2 days), plus placebo (group P) or IV hydration, NAC,
and Theophylline (200 mg in 100 ml 0.9% saline, as IV infusion 30 minutes before
contrast-medium (CM) administration) (group T). Patients underwent standard
coronary angiography +/- angioplasty. Serum creatinine (SCr) was assessed just before
and 72 h after contrast administration and estimated glomerular filtration rate (eGFR)
was calculated according to the Modification of Diet in Renal Disease (MDRD)
formula. CIN was defined as an increase in SCr concentration of >= 0.5 mg/dl or >=
25% after 72 h of CM injection.
Results: Among group P, 6 patients (20%) developed CIN while none of the patients
in group T developed CIN. Theophylline also significantly decreased SCr (p=0.0001)
and increased eGFR (p=0.001) at 72 hours. Regression analysis showed that anemia,
chronic renal impairment, high CM dose, and advanced age were independent
predictors for deteriorating renal function after CM administration.
Conclusion: Theophylline seems to be an effective prophylaxis against CIN for
moderate and higher risk patients undergoing coronary angiography or angioplasty. It
offers additive protection when added to IV hydration and NAC.
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Background: Renal dysfunction is associated with worse mortality following acute
coronary syndromes. However there is a paucity of data assessing this relationship
after primary PCI (PPCI) for STEMI.
Methods: Prospective data upon 1503 patients who underwent PPCI at a tertiary
cardiac centre between 2004 and 2010 was analysed. Patients were grouped by
estimated glomerular filtration rate (eGFR) (calculated using the modified diet in renal
disease equation) into chronic kidney disease stage 4 (CKD4) (eGFR 15 to 30 ml/min),
CKD3b (eGFR 30 to 45 mls/min), CKD3a (eGFR 45 to60 mls/min) and CKD1/2
(eGFR>60mls/min). Mortality data was collected from the Office of National Statistics.
3-year composite of MACE (death, reinfarction, stroke and target vessel
revascularisation) were compared between groups.
Results: 25 patients were in the CKD4 group, 95 patients in the CKD3b group, 282
patients in the CKD3a group and 1101 patients in the CKD1/2group. Co-morbidity
including hypertension, diabetes mellitus, previous MI and left ventricular impairment
were more common in patients with lower eGFR. In hospital MACE was more frequent
in patients with lower eGFR(32% in CKD4 vs 13.7% in CKD3b vs 10.3% in CKD3a
vs 3.6 in CKD1/2, p<0.0001). Long term MACE was increased with declining eGFR
(OR=4.84, 95%CI 2.94 to 7.96, when comparing the highest and lowest eGFR
groups)(Figure.1). After adjustment renal function based on the eGFR at admission
remained a strong independent predictor of outcome.
Conclusion: Baseline renal dysfunction in patients undergoing primary PCI is
associated with an increased risk for combined death, re-infarction and recurrent
angina. This risk increases linearly with declining eGFR.
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Background: Impaired renal function is well known potent predictor of contrast
induced nephropathy (CIN). Serum creatinine and creatinine based estimated
glomerular filtration rate are the most commonly used biomarker of renal function, but
they have many limitation in accuracy. The purpose of this study is to evaluate whether
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